QQQ   293.72 (+0.12%)
AAPL   148.31 (+0.19%)
MSFT   254.69 (-0.18%)
META   120.44 (+1.98%)
GOOGL   100.99 (+0.00%)
AMZN   95.50 (-1.08%)
TSLA   194.70 (+0.00%)
NVDA   171.35 (+1.25%)
NIO   12.09 (-5.40%)
BABA   85.94 (-1.85%)
AMD   77.48 (-0.19%)
T   19.19 (-0.47%)
MU   55.49 (-3.75%)
CGC   3.93 (+8.56%)
F   14.08 (+1.29%)
GE   85.26 (-0.83%)
DIS   98.59 (+0.74%)
AMC   8.17 (+13.00%)
PYPL   78.53 (+0.15%)
PFE   51.08 (+1.90%)
NFLX   316.95 (+3.74%)
QQQ   293.72 (+0.12%)
AAPL   148.31 (+0.19%)
MSFT   254.69 (-0.18%)
META   120.44 (+1.98%)
GOOGL   100.99 (+0.00%)
AMZN   95.50 (-1.08%)
TSLA   194.70 (+0.00%)
NVDA   171.35 (+1.25%)
NIO   12.09 (-5.40%)
BABA   85.94 (-1.85%)
AMD   77.48 (-0.19%)
T   19.19 (-0.47%)
MU   55.49 (-3.75%)
CGC   3.93 (+8.56%)
F   14.08 (+1.29%)
GE   85.26 (-0.83%)
DIS   98.59 (+0.74%)
AMC   8.17 (+13.00%)
PYPL   78.53 (+0.15%)
PFE   51.08 (+1.90%)
NFLX   316.95 (+3.74%)
QQQ   293.72 (+0.12%)
AAPL   148.31 (+0.19%)
MSFT   254.69 (-0.18%)
META   120.44 (+1.98%)
GOOGL   100.99 (+0.00%)
AMZN   95.50 (-1.08%)
TSLA   194.70 (+0.00%)
NVDA   171.35 (+1.25%)
NIO   12.09 (-5.40%)
BABA   85.94 (-1.85%)
AMD   77.48 (-0.19%)
T   19.19 (-0.47%)
MU   55.49 (-3.75%)
CGC   3.93 (+8.56%)
F   14.08 (+1.29%)
GE   85.26 (-0.83%)
DIS   98.59 (+0.74%)
AMC   8.17 (+13.00%)
PYPL   78.53 (+0.15%)
PFE   51.08 (+1.90%)
NFLX   316.95 (+3.74%)
QQQ   293.72 (+0.12%)
AAPL   148.31 (+0.19%)
MSFT   254.69 (-0.18%)
META   120.44 (+1.98%)
GOOGL   100.99 (+0.00%)
AMZN   95.50 (-1.08%)
TSLA   194.70 (+0.00%)
NVDA   171.35 (+1.25%)
NIO   12.09 (-5.40%)
BABA   85.94 (-1.85%)
AMD   77.48 (-0.19%)
T   19.19 (-0.47%)
MU   55.49 (-3.75%)
CGC   3.93 (+8.56%)
F   14.08 (+1.29%)
GE   85.26 (-0.83%)
DIS   98.59 (+0.74%)
AMC   8.17 (+13.00%)
PYPL   78.53 (+0.15%)
PFE   51.08 (+1.90%)
NFLX   316.95 (+3.74%)
NYSE:EFX

Equifax - EFX Price Target & Analyst Ratings

$202.25
+4.88 (+2.47%)
(As of 12/1/2022 12:00 AM ET)
Add
Compare
Today's Range
$197.40
$202.78
50-Day Range
$150.24
$207.10
52-Week Range
$145.98
$300.11
Volume
979,221 shs
Average Volume
985,194 shs
Market Capitalization
$24.76 billion
P/E Ratio
35.11
Dividend Yield
0.79%
Price Target
$205.21

Equifax Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 15 Analyst Ratings

Consensus Analyst Price Target

$205.21
1.47% Upside
High Prediction$245.00
Average Prediction$205.21
Low Prediction$158.00
TypeCurrent
12/1/21 to 12/1/22
1 Month Ago
11/1/21 to 11/1/22
3 Months Ago
9/2/21 to 9/2/22
1 Year Ago
12/1/20 to 12/1/21
Consensus Rating
Moderate Buy
Hold
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
8 Buy rating(s)
6 Buy rating(s)
9 Buy rating(s)
7 Buy rating(s)
Hold
7 Hold rating(s)
10 Hold rating(s)
8 Hold rating(s)
7 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$205.21$209.33$245.13$254.35
Predicted Upside1.47% Upside13.08% Upside12.46% Upside4.98% Upside
Get Equifax Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for EFX and its competitors with MarketBeat's FREE daily newsletter.


EFX Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

EFX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Equifax Stock vs. The Competition

TypeEquifaxBusiness Services CompaniesS&P 500
Consensus Rating Score
2.53
2.57
2.48
Consensus RatingModerate BuyBuyHold
Predicted Upside1.47% Upside338.44% Upside11.38% Upside
News Sentiment RatingNeutral News
Positive News
Neutral News
MarketBeat
Community Rating
Outperform Votes
577
64.83%
Underperform Votes
313
35.17%
Avg. Outperform Votes
173
64.07%
Avg. Underperform Votes
97
35.93%
Avg. Outperform Votes
853
68.13%
Avg. Underperform Votes
399
31.87%

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/25/2022Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$199.00 ➝ $223.00+12.67%
11/18/2022JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$196.00 ➝ $219.00+10.04%
11/15/2022Atlantic Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Overweight$230.00+16.21%
11/14/2022Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$190.00 ➝ $230.00+18.56%
10/21/2022Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight$200.00 ➝ $165.00+11.36%
10/21/2022The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral$215.00 ➝ $187.00+26.21%
10/21/2022Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight$212.00 ➝ $192.00+29.58%
10/20/2022Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Ashish Sabadra
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Sector Perform$195.00 ➝ $158.00+5.17%
10/19/2022Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$250.00 ➝ $161.00-2.98%
10/18/2022Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold$221.00 ➝ $185.00+12.64%
10/4/2022Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight$230.00 ➝ $225.00+29.80%
7/22/2022Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$250.00 ➝ $230.00+14.54%
7/21/2022Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$250.00 ➝ $245.00+19.41%
7/1/2022Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$254.00 ➝ $223.00+22.00%
3/11/2022Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageNeutral ➝ Neutral
11/22/2021Exane BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
George Gregory
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Neutral$296.06 ➝ $290.00+1.32%
10/22/2021Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$285.00+11.56%
10/14/2021Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform
1/19/2021CIBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageNeutral$8.50-95.18%
8/17/2020Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Brett Huff
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Target$173.00 ➝ $186.00+12.59%
6/9/2020SunTrust Banks
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$165.00-6.78%
4/21/2020Cfra
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold$173.00 ➝ $141.00+6.38%
(Data available from 12/1/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)












EFX Price Target - Frequently Asked Questions

What is Equifax's consensus rating and price target?

According to the issued ratings of 15 analysts in the last year, the consensus rating for Equifax stock is Moderate Buy based on the current 7 hold ratings and 8 buy ratings for EFX. The average twelve-month price prediction for Equifax is $205.21 with a high price target of $245.00 and a low price target of $158.00. Learn more on EFX's analyst rating history.

Do Wall Street analysts like Equifax more than its competitors?

Analysts like Equifax less than other Business Services companies. The consensus rating for Equifax is Moderate Buy while the average consensus rating for business services companies is Buy. Learn more on how EFX compares to other companies.

Do MarketBeat users like Equifax more than its competitors?

MarketBeat users like Equifax more than other Business Services companies. 64.83% of MarketBeat users gave Equifax an outperform vote while business services companies recieve an average of 64.18% outperform votes by MarketBeat users.

Is Equifax being upgraded or downgraded by Wall Street analysts?

Over the previous 90 days, Equifax's stock had 2 downgrades and 1 upgrade by analysts.

Does Equifax's stock price have much upside?

According to analysts, Equifax's stock has a predicted upside of 16.04% based on their 12-month price targets.


Stock Ratings Reports and Tools

This page (NYSE:EFX) was last updated on 12/1/2022 by MarketBeat.com Staff